{"schema_version":"1","generated_at":"2026-11-06T15:51:36.117Z","data_as_of":null,"url":"https://www.findmykol.com/kol/roy-kao","json_url":"https://www.findmykol.com/kol/roy-kao/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"roy-kao","name":"Roy Kao","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"University of Minnesota","institution_url":"https://www.findmykol.com/institution/university-of-minnesota","city":"Minneapolis","state":"MN","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1407058076","orcid":"0000-0002-1985-8870","openalex":"A5003302652"},"summary":"Roy Kao is an Oncology physician affiliated with University of Minnesota. OpenAlex indexes 40 publications with 430 citations (h-index 9).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":40,"cited_by_count":430,"h_index":9,"latest_activity_year":2026,"emerging":true,"source":"works"},"payments":{"company_count":2,"program_years":{"first":2021,"last":null},"rows_total":5,"shown":3,"withheld":2,"rows":[{"payer":"bluebird bio","program_year":2025,"amount_usd":35389.5,"payment_count":7,"source_url":"https://openpaymentsdata.cms.gov/search?query=1407058076"},{"payer":"Vertex","program_year":2025,"amount_usd":3250,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1407058076"},{"payer":"VERTEX PHARMACEUTICALS INCORPORATED","program_year":2025,"amount_usd":57.2,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1407058076"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1407058076","source":"payments"},"prescribing":{"data_year":2024,"areas_total":7,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":32.5,"classes_total":3,"classes":[{"class":"Antimetabolite","setting":"prescribed","share_pct":14.1,"drugs":[{"name":"Hydroxyurea","share_pct":100}],"max_beneficiaries":null},{"class":"Kinase inhibitor","setting":"prescribed","share_pct":12,"drugs":[{"name":"Jakafi","share_pct":52.2},{"name":"Rydapt","share_pct":47.8}],"max_beneficiaries":null}]},{"area":"Nervous system","share_pct":23.6,"classes_total":2,"classes":[{"class":"Opioid Agonist","setting":"prescribed","share_pct":17.8,"drugs":[{"name":"Morphine Sulfate Er","share_pct":52.9},{"name":"Oxycodone Hcl","share_pct":47.1}],"max_beneficiaries":null},{"class":"gamma-Aminobutyric Acid A Receptor Positive Modulator","setting":"prescribed","share_pct":5.8,"drugs":[{"name":"Zolpidem Tartrate","share_pct":100}],"max_beneficiaries":null}]},{"area":"Dermatology","share_pct":18.3,"classes_total":1,"classes":[{"class":"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor","setting":"prescribed","share_pct":18.3,"drugs":[{"name":"Acyclovir","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":40,"shown":5,"withheld":35,"matched_by":"OpenAlex author record","recent":[{"title":"CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat β-Thalassemia","year":2026,"journal":"New England Journal of Medicine","source_url":"https://doi.org/10.1056/nejmoa2501277","status":"verified"},{"title":"Advanced fibrosis, TP53 variants and acute/pure erythroid leukaemia: Diagnostic harbingers of ERCC6L2 ‐related bone marrow failure syndrome?","year":2026,"journal":"British Journal of Haematology","source_url":"https://doi.org/10.1111/bjh.70666","status":"verified"},{"title":"Clinical Impact of Reduced-Dose Levofloxacin Pre-Engraftment Bacterial Prophylaxis In 3093 Allogeneic and 1719 Autologous Adult and Pediatric HCT Recipients at a Single Institution","year":2026,"journal":"Transplantation and Cellular Therapy","source_url":"https://doi.org/10.1016/j.jtct.2026.02.019","status":"verified"},{"title":"A united-states nationwide analysis of sickle cell genotype-specific differences in inpatient outcomes","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-945","status":"verified"},{"title":"Pilot of standardized cognitive behavioral therapy for young adults with sickle cell disease","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-4752","status":"verified"}],"source":"works"},"contact":{"address_1":"500 HARVARD ST SE","city":"Minneapolis","state":"MN","zip":"55455","phone":"612-273-3000","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1407058076","source":"identity"},"similar":[{"name":"Jay Cohn","slug":"jay-cohn","institution":"University of Minnesota","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/jay-cohn","json_url":"https://www.findmykol.com/kol/jay-cohn/profile.json"},{"name":"Douglas Yee","slug":"douglas-yee","institution":"University of Minnesota","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/douglas-yee","json_url":"https://www.findmykol.com/kol/douglas-yee/profile.json"},{"name":"David Benditt","slug":"david-benditt","institution":"University of Minnesota","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/david-benditt","json_url":"https://www.findmykol.com/kol/david-benditt/profile.json"},{"name":"Stuart Grossman","slug":"stuart-grossman","institution":"University of Minnesota","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/stuart-grossman","json_url":"https://www.findmykol.com/kol/stuart-grossman/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":2,"publications":35}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2025-03-17","provider_certified":"2025-03-17","collected_at":"2026-11-05T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}